Services

Taken from statistics as published by the Royal College of Surgeons, Clinical Effectiveness Unit, November 2012 in the UK Liver Transplant Audit.

A pioneer in liver transplantation since 1966, the Liver Transplant Centre uses state of the art technology and leading medical and surgical interventions to provide individualised, on-going care for adult and paediatric patients with liver disease. Our Liver Transplant Programme provides complete treatment, transplant and management options for patients with acute or chronic liver disease as well as patients with liver cancer.

Our patients receive integrated, comprehensive care beginning with a careful assessment and evaluation of ensure that transplantation is the patient's best treatment option.

For international patients, King's offers a "living donor" liver transplantation programme and the donors and recipients are carefully assessed to ensure the best outcomes for both the patient and the donor.

The Liver Intensive Therapy service is an integral part of the largest comprehensive liver programme in the world. It provides integrated investigation and treatment for all types of acute and chronic liver diseases as well as research into pathogenesis and future patient management.

The Unit is a unique specialist facility with a worldwide reputation, staffed by a specialist team of intensive care doctors, it has been setting international standards for patient care for more than two decades and is a leading centre for the development and use of advanced and innovative therapies. The Unit has a particular pedigree in the management of acute and chronic liver disease, and treats more patients with acute liver failure than any other similar centre in the world, and supports Europe's largest liver transplantation programme.

The LITU has 15 beds for the care of critically ill liver patients and offers single-sex accommodation, bathroom and toilet facilities.

The King’s viral hepatitis service is one of the largest specialist treatment centres for the condition in the UK. We offer high-quality, state-of-art treatment for viral hepatitis B and C patients as well as those also infected (co-infected) with hepatitis D (HDV) and the human immunodeficiency virus (HIV).

King's is involved in several on-going studies evaluating the safety and efficacy of various antiviral treatment regimens for chronic hepatitis B and C and have already introduced new drug treatments.

We provide all-round care for people with liver, biliary and gall bladder disorders. Our team offers specialist investigations and care for conditions such as:

• primary liver cancer: hepatocellular carcinoma (HCC)
• benign liver tumours: focal nodular hyperplasia (FNH), adenoma, haemangioma
• biliary cystadenoma
• primary biliary cancers: cholangiocarcinoma and gallbladder cancer
• secondary liver tumours from a colorectal, breast or other primary

Treatments include:

• liver and biliary resection
• percutaneous radio-frequency ablation of primary and secondary liver tumours
• percutaneous chemo-embolisation for primary liver tumours
• percutaneous bland embolisation for liver tumours
• endoscopic radio-frequency ablation for biliary tumours
• Selective Internal Radiation Therapy (SIRT) for primary or secondary liver tumours
• sorafenib for primary liver cancer - hepatocellular carcinoma (HCC)
• specialist endoscopy.